Zacks Investment Research
25 Jun 2026, 14:55 UTC · 19w ago
Impact · against what's priced in
Lumexa (LMRI) shows strong bullish indicators based on analyst consensus and earnings estimate revisions. While the stock has already climbed nearly 30% recently, the mean price target of $17.29 suggests significant remaining upside.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish
Wall Street analysts have a mean short-term price target of $17.29 for Lumexa (LMRI), representing a potential 73.3% upside from its last close of $9.98.
So whatA high consensus price target can drive buying interest and upward momentum for a specific ticker.
More positive than 93% of claims this week
Analysts are showing strong agreement regarding Lumexa's ability to report earnings that exceed previous predictions.
So whatPositive earnings estimate revisions are typically a strong leading indicator of stock price appreciation.
Continue reading
5 related stories
Wall Street analysts maintain a mean price target of $17.29, implying 73.3% upside from the current price of $9.98, supported by agreement that earnings will exceed previous predictions.
Read from the article alone
Scored by the NIS engine · methodology.
More positive than 76% of claims this week
Lumexa's stock price has already increased by 29.3% over the past four weeks.
More positive than 51% of claims this week
Which stocks this story touches
More positive than 89% of ticker scores this week
The company has seen a 29.3% price gain and has a mean analyst price target suggesting significant upside potential.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
5h ago
+59.6%
Price agrees with the score
$15.93 vs $9.98 close before publication (Jun 24) · not market-adjusted
LMRI chart →
